Petredis Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
26,255
-48
-0.2% -$3.87K 0.14% 82
2026
Q1
$2.28M Sell
26,303
-208
-0.8% -$19.9K 0.19% 80
2025
Q4
$2.55M Sell
26,511
-307
-1% -$29.8K 0.2% 77
2025
Q3
$2.55M Sell
26,818
-358
-1% -$32.9K 0.2% 78
2025
Q2
$2.37M Buy
27,176
+414
+2% +$35.1K 0.21% 80
2025
Q1
$2.4M Buy
26,762
+596
+2% +$53.3K 0.25% 71
2024
Q4
$2.09M Sell
26,166
-768
-3% -$66.5K 0.22% 76
2024
Q3
$2.42M Buy
26,934
+74
+0.3% +$6.22K 0.26% 73
2024
Q2
$2.11M Sell
26,860
-39
-0.1% -$3.2K 0.24% 76
2024
Q1
$2.34M Buy
26,899
+692
+3% +$59.1K 0.28% 72
2023
Q4
$2.16M Buy
+26,207
New +$2M 0.28% 72
2023
Q3
Sell
-16,957
Closed -$1.49M 96
2023
Q2
$1.49M Buy
16,957
+165
+1% +$14.2K 0.21% 85
2023
Q1
$1.35M Buy
16,792
+1,595
+10% +$130K 0.21% 83
2022
Q4
$1.18M Buy
+15,197
New +$1.23M 0.21% 82

Other funds holding MDT

Petredis Investment Advisors's MDT Position: Q2 2026 in Review

Petredis Investment Advisors reduced its Medtronic (MDT) stake by 0.18% in Q2 2026, selling an estimated $3.87K and leaving 26,255 shares worth $2.05M. The position accounts for 0.14% of the portfolio, ranked #82.

Petredis Investment Advisors first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.55M in Q3 2025. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Petredis Investment Advisors held 26,255 shares of Medtronic worth $2.05M as of Q2 2026.
  • Petredis Investment Advisors sold 48 Medtronic shares in Q2 2026, an estimated $3.87K.
  • Medtronic made up 0.14% of Petredis Investment Advisors's portfolio in Q2 2026, its #82 holding.
  • Petredis Investment Advisors first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
  • Petredis Investment Advisors's Medtronic position peaked at $2.55M in Q3 2025.
  • 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Petredis Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.